Trading Options with an Edge
Select Page

ALT

Search by
TICKER SYMBOL

Altimmune Inc

Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing

14.86

0.29

(1.99%)

Volume:

272,854

52 week range:

7.8 - 24.61

Market Cap:

590.029M

Company Description:

Altimmune is a clinical stage biopharmaceutical company focused on developing intranasal vaccines, immune modulating therapies and treatments for liver disease. Its diverse pipeline includes proprietary intranasal vaccines for COVID-19 (AdCOVID™), anthrax (NasoShield™) and influenza (NasoVAX™); an intranasal immune modulating therapeutic for COVID-19 (T-COVID™); and next generation peptide therapeutics for NASH (ALT-801) and chronic hepatitis B (HepTcell™).